<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN" "JATS-journalpublishing1-4.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.4" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">ojog</journal-id>
      <journal-title-group>
        <journal-title>Open Journal of Obstetrics and Gynecology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2160-8806</issn>
      <issn pub-type="ppub">2160-8792</issn>
      <publisher>
        <publisher-name>Scientific Research Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.4236/ojog.2025.1512189</article-id>
      <article-id pub-id-type="publisher-id">ojog-148501</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
        <subj-group>
          <subject>Medicine</subject>
          <subject>Healthcare</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Prevalence and Factors Associated with Viral Hepatitis B and C at the Ebolowa Regional Hospital Center</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Yannick</surname>
            <given-names>Messakop Moayeth</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Isabelle</surname>
            <given-names>Lendem</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ulrich</surname>
            <given-names>Bisay Souhe</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Huguette</surname>
            <given-names>Atangana Ekobo</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Veronique</surname>
            <given-names>Mboua Ndenga</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Leslie</surname>
            <given-names>Bilo’o</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Stephanie</surname>
            <given-names>Makemgue Louise</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Annick</surname>
            <given-names>Ndoumba</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Clovis</surname>
            <given-names>Elah</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Flaure</surname>
            <given-names>Aboui</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vianey</surname>
            <given-names>Ntone Samuel</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rody</surname>
            <given-names>Bengono</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pascal</surname>
            <given-names>Foumane</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Michel</surname>
            <given-names>Ekono Guy</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">7</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label> Department of Gynecology and Human Reproduction, FMPS University of Ebolowa, Ebolowa, Cameroon </aff>
      <aff id="aff2"><label>2</label> Department of Biology, FS University of Ebolowa, Ebolowa, Cameroon </aff>
      <aff id="aff3"><label>3</label> Department of Surgery and Specialties, FMPS University of Ebolowa, Ebolowa, Cameroon </aff>
      <aff id="aff4"><label>4</label> Department of Internal Medecine, FMPS University of Ebolowa, Ebolowa, Cameroon </aff>
      <aff id="aff5"><label>5</label> Department of Paediatrics, FMPS University of Ebolowa, Ebolowa, Cameroon </aff>
      <aff id="aff6"><label>6</label> Ebolowa Regional Health Center, Ebolowa, Cameroon </aff>
      <aff id="aff7"><label>7</label> Department of Gynecology, FMPS University of Douala, Douala, Cameroon </aff>
      <author-notes>
        <fn fn-type="conflict" id="fn-conflict">
          <p>The authors declare no conflicts of interest regarding the publication of this paper.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>12</month>
        <year>2025</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2025</year>
      </pub-date>
      <volume>15</volume>
      <issue>12</issue>
      <fpage>2235</fpage>
      <lpage>2246</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>11</month>
          <year>2025</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>12</month>
          <year>2025</year>
        </date>
        <date date-type="published">
          <day>31</day>
          <month>12</month>
          <year>2025</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2025 by the authors and Scientific Research Publishing Inc.</copyright-statement>
        <copyright-year>2025</copyright-year>
        <license license-type="open-access">
          <license-p> This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link> ). </license-p>
        </license>
      </permissions>
      <self-uri content-type="doi" xlink:href="https://doi.org/10.4236/ojog.2025.1512189">https://doi.org/10.4236/ojog.2025.1512189</self-uri>
      <abstract>
        <p><bold>Introduction:</bold> Viral hepatitis B is a major problem during pregnancy because of its impact on maternal and foetal well-being. Our aim was to determine the prevalence and factors associated with viral hepatitis B during pregnancy at the Ebolowa regional hospital center (ERHC). <bold>Methodology:</bold> We conducted a descriptive and analytical cross-sectional study from June 2023 to June 2025, including all pregnant women seen at the Ebolowa regional hospital center during the study period who had undergone a rapid screening test for hepatitis B and C, confirmed by an ELISA test if positive. Sociodemographic, clinical, paraclinical and therapeutic data were collected and analysed using SPSS version 28.0 software, with a confidence interval of 95% and a significance threshold set at p &lt; 0.05. <bold>Results:</bold> During the study period, 480 pregnant women were included. Of these, 38 women tested positive for hepatitis B surface antigen (HBsAg), for a prevalence of 7.9%, and 3 for Hepatitis C antibody (HCV-Ab), for a prevalence of 0.6%. The mean age of these hepatitis B virus-positive patients was 27.9 ± 4.7 years (range: 18 to 43 years). The highest prevalence of hepatitis B was in the 21-30 age group (59%), among housewives (62%), single women (60%) and multiparous women (54.5%). Family history of hepatitis B virus (OR = 2.1; CI [1.22 - 5.51], p = 0.001), single marital status (OR = 3.79; CI [2.63 - 7.52], p = 0.032) and age (21 - 30 years) (OR = 6.01; CI [2.40 - 20.21], p = 0.005) were the factors independently associated with viral hepatitis B. <bold>Conclusion:</bold> Viral hepatitis B remains a health problem among pregnant women treated at the ERHC, and several risk factors were identified, in line with the literature.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated" xml:lang="en">
        <kwd>Prevalence</kwd>
        <kwd>Associated Factors</kwd>
        <kwd>Hepatitis B</kwd>
        <kwd>Pregnant Women</kwd>
        <kwd>Ebolowa</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>1. Introduction</title>
      <p>Viral hepatitis remains a major health problem worldwide and especially in low income countries like Cameroon because of its widespread transmission, high cost of prevention and treatment. Hepatitis B (HBV) is an enveloped partially double stranded virus belonging to the family Hepadnavirus [<xref ref-type="bibr" rid="B1">1</xref>]-[<xref ref-type="bibr" rid="B3">3</xref>]. Transmission is mostly sexual, blood transfusions, and exchange of body fluids but perinatal transmission accounts for more than 50% of cases worldwide[<xref ref-type="bibr" rid="B1">1</xref>]. Usually this virus does not cross the maternal-foetal barrier admist breaks in this barrier during pregnancy or delivery. Materno-foetale transmission rate is high (90%) among pregnant women with Chronic HBV and positive HBV E antigen [<xref ref-type="bibr" rid="B4">4</xref>][<xref ref-type="bibr" rid="B5">5</xref>]. </p>
      <p>Hepatitis C virus (HCV) infection is a significant global public health concern, affecting approximately 21% of individuals of childbearing age [<xref ref-type="bibr" rid="B1">1</xref>]. According to the WHO report in 2022 about 2.2 and 5.3 million HCV-positive babies are born worldwide each year [<xref ref-type="bibr" rid="B3">3</xref>]. Perinatal transmission is also possible during pregnancy as Mothers infected with HCV have been shown to have about a 7.2% risk of perinatal transmission. Hence screening should be sytematic during pregnancy and trisk factors sought.</p>
      <p>In 2022, the World Health Organization (WHO) estimated that 254 million people lived with chronic hepatitis B with 1.2 million new infections and an estimated 1.1 million deaths that year [<xref ref-type="bibr" rid="B3">3</xref>]. The global prevalence of HBV was estimated at 4.1% and 6.7% among pregnant women [<xref ref-type="bibr" rid="B3">3</xref>]. This prevalence varies significantly from one region to the other but Africa and Asia carry the largest burden with rates often high reaching over 8 % or even higher in certain regions [<xref ref-type="bibr" rid="B3">3</xref>]-[<xref ref-type="bibr" rid="B7">7</xref>]. This variability might be linked to differences in diagnostic methods, study population type and regional endemicity. Notwithstanding the pool prevalence of Hepatitis B in pregnancy in Africa is 5.89% [<xref ref-type="bibr" rid="B8">8</xref>]-[<xref ref-type="bibr" rid="B23">23</xref>]. </p>
      <p>The national prevalence of hepatitis B in Cameroon was 11.2% in 2017 and prevalence among pregnant women varies by region and study but generally falls in a high endemic range with national estimates at 9.8% and estimates ranging from 5.4% to over 18% in certain regions. These high rates in Cameroon highlights the need for expanded screening and vaccination programs for pregnant women and newborns [<xref ref-type="bibr" rid="B7">7</xref>]. Fouelifack <italic>et al</italic>. in 2018 had a national prevalence of hepatitis C infection of 1.6% [<xref ref-type="bibr" rid="B24">24</xref>].</p>
      <p>Several studies have concluded that the risk of hepatitis B seroprevalence increased with low income, blood transfusion, multiple sexual partners, ear piercings and tattoos and recommended widespread education on hepatitis B prevention [<xref ref-type="bibr" rid="B8">8</xref>]-[<xref ref-type="bibr" rid="B20">20</xref>]. The WHO aimed at eradicating Hepatitis B as a treat to health by 2030 and prevention of mother-to-child HBV transmission seems critical for the global elimination of viral hepatitis [<xref ref-type="bibr" rid="B2">2</xref>]. Systematic screening for hepatitis B surface antigen in pregnancy, tenofovir for the treatment of viral hepatitis from the 28<sup>th</sup> week of pregnancy, implementation of elimination of mother to child transmission intervention during labour, improvement of of 3 doses of hepatitis B vaccine and hepatitis B birth dose coverage alongside administering Hepatitis B Immunoglobulin to this infants within 12 hours of birth are measures to reduce mother to child transmission of HBV [<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>Cameroon introduced the hepatitis B vaccine and expanded immunisation program in 2005 and few studies have been carried out on the prevalence of hepatitis virus B in the south region of Cameroun with its headquarter, Ebolowa. We therefor aimed at determining the prevalence and associated factors to viral hepatitis B in pregnancy at the Ebolowa Regional Health Center.</p>
    </sec>
    <sec id="sec2">
      <title>2. Methodology</title>
      <p>We conducted a descriptive and analytical cross-sectional study from June 2023 to June 2025 on women attending antenatal care at the Ebolowa Regional Health Center. We included all pregnant women attending antenatal care at the ERHC during the data collection period. Were excluded pregnant women who had received hepatitis B vaccine, those vaccined against hepatitis B and pregnant women who refused to give their written concern to take part in the study.</p>
      <p>Sample size determination was done using a one-population proportion formula. n = (Zα/2)2 p (1 − p)/d2 assuming that: </p>
      <p>P = prevalence of hepatitis B virus taken from the study done by Evenge Nzechieu in Cameroon , Buea, 2023 which was 8.4%.α = 0.05,Z = Level of confidence interval 95% = 1.96, d = Degree of precession were used to obtain 361 pregnant mothers.</p>
      <p>After obtaining a written concern from the patient, data was collected on a daily basis by a trained personnel using a pretested questionnaire. Data collected included sociodemographic data, clinical data and behavioral factors and practices. An experienced laboratory technician hence collected 5 ml of veinous blood from each participant and after centrifugation at 3,00 rpm for 5 mins carried out a rapid diagnostic tests to detect (RDT) hepatitis B. In case of positive RDT results was confirmed analysing serum samples for the presence of hepatitis B surface antigen using an ELISA reader (Mindray, China)</p>
      <p>The collected data were checked for completeness, inserted in microsoft excel and exported to SPSS version 28.0 for analysis. Statistical significant association at the bivariate analysis were put in a multiple regression model to adjust for any possible confounders and results presented in the form of Tables, pie charts and graphs. Pearson’s χ<sup>2</sup> test was used to compare prevalence of hepatitis in different groups. Our confidence interval was set at 95% for a significance threshold of p &lt; 0.05. Adjusted Odds Ratio (AOR) with 95% confidence interval (CI) was used as a measure of association.</p>
    </sec>
    <sec id="sec3">
      <title>3. Results</title>
      <sec id="sec3dot1">
        <title>3.1. Sociodemographic Profile of the Studied Population</title>
        <p>During the study period, 480 pregnant women were included with a response rate of 100%. The mean age of our participants was 27.9 ± 4.7 years (range: 18 to 43 years). Most of them were single (60%), had a secondary level of education (57%). Our respondents mostly lived in an urban area (81.5%) and were government employees (43.2%). As illustrated on<bold>Table 1</bold>.</p>
        <p><bold>Table 1.</bold> Sociodemographic characteristics of pregnant women screened for viral hepatitis at the Ebolowa Regional Health Center.</p>
        <table-wrap id="tbl1">
          <label>Table 1</label>
          <table>
            <tbody>
              <tr>
                <td colspan="2">
                  <bold>Characteristics of women</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Mean age (years)</bold>
                </td>
                <td>27.9 ± 4.7</td>
              </tr>
              <tr>
                <td>
                  <bold>Marital status, n (%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Maried</td>
                <td>190 (39.5)</td>
              </tr>
              <tr>
                <td>Single</td>
                <td>288 (60.0)</td>
              </tr>
              <tr>
                <td>Widow</td>
                <td>2 (0.5)</td>
              </tr>
              <tr>
                <td>
                  <bold>Residence, n (%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Urban</td>
                <td>392 (81.5)</td>
              </tr>
              <tr>
                <td>Rural</td>
                <td>88 (18.5)</td>
              </tr>
              <tr>
                <td>
                  <bold>Level of education, n (%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>No education</td>
                <td>50 (10.5)</td>
              </tr>
              <tr>
                <td>Primary</td>
                <td>65 (13.5)</td>
              </tr>
              <tr>
                <td>Secondary</td>
                <td>274 (57.0)</td>
              </tr>
              <tr>
                <td>University</td>
                <td>91 (19.0)</td>
              </tr>
              <tr>
                <td>
                  <bold>Age group, n (%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>≤ 20</td>
                <td>37 (7.7)</td>
              </tr>
              <tr>
                <td>21 - 30</td>
                <td>240 (50)</td>
              </tr>
              <tr>
                <td>31 - 40</td>
                <td>160 (33.3)</td>
              </tr>
              <tr>
                <td>41 - 45</td>
                <td>43 (9.0)</td>
              </tr>
              <tr>
                <td>
                  <bold>Profession,</bold>
                  <bold>n (%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Unemployed</td>
                <td>107 (22.3)</td>
              </tr>
              <tr>
                <td>Private sector</td>
                <td>166 (34.5)</td>
              </tr>
              <tr>
                <td>Public sector</td>
                <td>207 (43.2)</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="sec3dot2">
        <title>3.2. Clinical Profile of the Studied Population</title>
        <p>When we considered their clinical characteristics, we found that most of our patients were primiparous (45%; 216/480) and were seen in the first trimester of pregnancy (50.2%; 241/480). On average, they had had 4.02 ± 1.70 sexual partners, and their mean age at first intercourse was 17 ± 2.0 years. The majority declared having had just one partner in the last six months (55%; 264/480), with no protection during their last intercourse (80%; 384/480). The use of condoms was rare, with only 28.7% (138/480) of our study population having ever used a condom during sex. Few of our patients had received a blood transfusion (10.6%; 51/480). The majority of respondents had never been scarified or shared sharp objects (73.1%; 351/480) and had never had any unsafe injections (96%; 461/480). Twenty percent (96/480) disclosed having a family history of viral hepatitis. We also found that only 3.5% of our patients had been vaccinated against hepatitis B. AS shown on<bold>Table 2</bold>.</p>
        <p><bold>Table 2.</bold> Clinical characteristics of pregnant women screened for viral hepatitis at the Ebolowa Regional Health Center.</p>
        <table-wrap id="tbl2">
          <label>Table 2</label>
          <table>
            <tbody>
              <tr>
                <td colspan="2">
                  <bold>Characteristics of women</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Average number of pregnancies</bold>
                </td>
                <td>2. ± 1.09</td>
              </tr>
              <tr>
                <td>
                  <bold>Parity, n (%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Primipara</td>
                <td>216(45.0)</td>
              </tr>
              <tr>
                <td>Paucipara</td>
                <td>104(21.7)</td>
              </tr>
              <tr>
                <td>Multipara</td>
                <td>160(33.3)</td>
              </tr>
              <tr>
                <td>
                  <bold>Gestational age, n (%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>First trimester</td>
                <td>241(50.2)</td>
              </tr>
              <tr>
                <td>Second trimester</td>
                <td>145(30.3)</td>
              </tr>
              <tr>
                <td>Third trimester</td>
                <td>94(19.5)</td>
              </tr>
              <tr>
                <td>
                  <bold>Average number of sexual partners</bold>
                </td>
                <td>4.02 ± 1.70</td>
              </tr>
              <tr>
                <td>
                  <bold>Number of sexual partners during the last six months, n (%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>None</td>
                <td>158 (33.0)</td>
              </tr>
              <tr>
                <td>1</td>
                <td>162 (55.0)</td>
              </tr>
              <tr>
                <td>At least 2</td>
                <td>58 (12.0)</td>
              </tr>
              <tr>
                <td>
                  <bold>Mean age at first sexual intercourse (years)</bold>
                </td>
                <td>17.0 ± 2.00</td>
              </tr>
              <tr>
                <td>
                  <bold>Protection last sexual intercourse, n (%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>No</td>
                <td>384 (80.0)</td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>96 (20.0)</td>
              </tr>
              <tr>
                <td>
                  <bold>Usage of condoms, n (%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Never</td>
                <td>102 (21.3)</td>
              </tr>
              <tr>
                <td>At times</td>
                <td>240 (50.0)</td>
              </tr>
              <tr>
                <td>Always</td>
                <td>138 (29.7)</td>
              </tr>
              <tr>
                <td>
                  <bold>Past history of blood transfusion</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>51 (10.6)</td>
              </tr>
              <tr>
                <td>No</td>
                <td>429 (89.4)</td>
              </tr>
              <tr>
                <td>
                  <bold>History of unsafe injection</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>19 (4)</td>
              </tr>
              <tr>
                <td>No</td>
                <td>461 (96)</td>
              </tr>
              <tr>
                <td>
                  <bold>Family History of Hepatitis B infection</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>96 (20)</td>
              </tr>
              <tr>
                <td>No</td>
                <td>384 (80)</td>
              </tr>
              <tr>
                <td>
                  <bold>Scarifications and share of sharp objects</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>129 (26.9)</td>
              </tr>
              <tr>
                <td>No</td>
                <td>351 (73.1)</td>
              </tr>
              <tr>
                <td>
                  <bold>Previous dental procedures</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>98 (20)</td>
              </tr>
              <tr>
                <td>No</td>
                <td>382 (79.5)</td>
              </tr>
              <tr>
                <td>
                  <bold>Vaccination against Hepatitis B</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>No</td>
                <td>175 (3.5)</td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>463 (96.5)</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="sec3dot3">
        <title>3.3. Prevalence of Viral Hepatitis B and C in Pregnancy</title>
        <p>Of these, 38 women tested positive for HBsAg, representing a prevalence of 7.9%, while three tested positive for HCV-Ab, representing a prevalence of 0.6%. We found no co-infection of HBV and HCV in our studied population. The highest prevalence of hepatitis B and HCV was found in the 21 - 30 age group (68.3%), in single women (80.5%), and in multiparous women (68.3%). See <bold>Tables 3-4</bold>.</p>
        <p><bold>Table 3.</bold>Seroprevalence of hepatitis B and C virus among pregnant women followed at the ERHC.</p>
        <table-wrap id="tbl3">
          <label>Table 3</label>
          <table>
            <tbody>
              <tr>
                <td>
                  <bold>Outcome variable</bold>
                  <bold>Status</bold>
                </td>
                <td>
                  <bold>Frequency (%)</bold>
                  <bold>N</bold>
                  <bold>=</bold>
                  <bold>480</bold>
                </td>
                <td>
                  <bold>95% CI</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>HBsAg</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Negative</td>
                <td>442(92.09)</td>
                <td>[33.10 - 98.99]</td>
              </tr>
              <tr>
                <td>Positive</td>
                <td>38 (7.91)</td>
                <td>[2.91 - 18.38]</td>
              </tr>
              <tr>
                <td>
                  <bold>Anti- HCV antibodies</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Negative</td>
                <td>477(99.4)</td>
                <td>[40.34 - 186.91]</td>
              </tr>
              <tr>
                <td>Positive</td>
                <td>3(0.6)</td>
                <td>[0.07 - 4.00]</td>
              </tr>
              <tr>
                <td>
                  <bold>Co-infection (HBsAg and HCV)</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Negative</td>
                <td>480 (100)</td>
                <td>[23.10 - 494.00]</td>
              </tr>
              <tr>
                <td>Positive</td>
                <td>0(0)</td>
                <td>1</td>
              </tr>
              <tr>
                <td>
                  <bold>Overall prevalence of viral hepatitis</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Positive</td>
                <td>41(8.54)</td>
                <td>[6.10 - 46.11]</td>
              </tr>
              <tr>
                <td>Negative</td>
                <td>439 (91.46)</td>
                <td>[3.00 - 100.04]</td>
              </tr>
              <tr>
                <td>Co iinfection</td>
                <td>0(0)</td>
                <td>1</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p><bold>Table 4.</bold>Descriptive analysis and logistic regression of risk factors associated with Hepatitis B infections among pregnant women at the ERHC.</p>
        <table-wrap id="tbl4">
          <label>Table 4</label>
          <table>
            <tbody>
              <tr>
                <td rowspan="3">
                </td>
                <td colspan="3">
                  <bold>Descriptive analysis</bold>
                </td>
                <td colspan="4">
                  <bold>Logistic regression analysis</bold>
                </td>
              </tr>
              <tr>
                <td colspan="3">
                  <bold>Chi-square</bold>
                </td>
                <td colspan="2">
                  <bold>Univariate</bold>
                </td>
                <td colspan="2">
                  <bold>Multivariate</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Negative</bold>
                  <bold>N</bold>
                  <bold>=</bold>
                  <bold>−</bold>
                  <bold>439</bold>
                </td>
                <td>
                  <bold>Positive</bold>
                  <bold>N</bold>
                  <bold>=</bold>
                  <bold>41</bold>
                </td>
                <td rowspan="2">
                  <bold>p-value</bold>
                </td>
                <td rowspan="2">
                  <bold>OR (95% CI)</bold>
                </td>
                <td rowspan="2">
                  <bold>p-Value</bold>
                </td>
                <td rowspan="2">
                  <bold>a OR (95% CI)</bold>
                </td>
                <td rowspan="2">
                  <bold>p-Value</bold>
                </td>
              </tr>
              <tr>
                <td>Characteristics</td>
                <td>n (%)</td>
                <td>n (%)</td>
              </tr>
              <tr>
                <td>
                  <bold>Age brackets</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td rowspan="5">
                  <bold>0.02</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>[≤20]</td>
                <td>33(7.5)</td>
                <td>4(9.8)</td>
                <td>1</td>
                <td>
                </td>
                <td>1</td>
                <td>
                </td>
              </tr>
              <tr>
                <td>[21 - 30]</td>
                <td>212(48.3)</td>
                <td>28(68.3)</td>
                <td>4.50 (0.13 - 5.673)</td>
                <td>
                  <bold>0.005</bold>
                </td>
                <td>4.40 (0.86 - 7.21)</td>
                <td>
                  <bold>0.005</bold>
                </td>
              </tr>
              <tr>
                <td>[31 - 40]</td>
                <td>155(35.3)</td>
                <td>5(12.2)</td>
                <td>1.02 (0.63 - 4.00)</td>
                <td>0.10</td>
                <td>1.01 (0.31 - 3.01)</td>
                <td>0.33</td>
              </tr>
              <tr>
                <td>[41 - 45]</td>
                <td>39(24.6)</td>
                <td>4 (4.3)</td>
                <td>0.27 (0.11 - 2.10)</td>
                <td>0.51</td>
                <td>0.22(0.12 - 3.63)</td>
                <td>0.41</td>
              </tr>
              <tr>
                <td>
                  <bold>Past history of blood transfusion</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td rowspan="3">0.66</td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>No</td>
                <td>409 (93.1)</td>
                <td>20(48.7)</td>
                <td>1</td>
                <td>
                </td>
                <td>1</td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>30(6.8)</td>
                <td>21(51.2)</td>
                <td>2.56 (0.21 - 3.20)</td>
                <td>0.08</td>
                <td>2.66 (0.28 - 4.01)</td>
                <td>0.10</td>
              </tr>
              <tr>
                <td>
                  <bold>Family history of hepatitis B infection</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td rowspan="2">
                  <bold>0.003</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>No</td>
                <td>373(84.9)</td>
                <td>11 (26.8)</td>
                <td>1</td>
                <td>
                </td>
                <td>1</td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>66(15.9)</td>
                <td>30 (73.2)</td>
                <td>
                </td>
                <td>5.06 (0.01 - 3.66)</td>
                <td>
                  <bold>0.003</bold>
                </td>
                <td>6.08 (0.2 - 11.67)</td>
                <td>
                  <bold>0.001</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Marital status</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td rowspan="3">
                  <bold>0.01</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Married</td>
                <td>43(62.3)</td>
                <td>31(13.4)</td>
                <td>0.31 (0.15 - 8.01)</td>
                <td>
                </td>
                <td>0.33 (0.05 - 9.11)</td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Single</td>
                <td>255 (53.1)</td>
                <td>33(80.5)</td>
                <td>4.02 (0.55 - 13.01)</td>
                <td>
                  <bold>0.0001**</bold>
                </td>
                <td>2.0 (0.68 - 21.02)</td>
                <td>
                  <bold>0.032</bold>
                </td>
              </tr>
              <tr>
                <td>Widow</td>
                <td>2(0.5)</td>
                <td>0(0)</td>
                <td>
                </td>
                <td>1.</td>
                <td>
                </td>
                <td>1.07 (0.90</td>
                <td>0.68</td>
              </tr>
              <tr>
                <td>
                  <bold>History of unsafe injection</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td rowspan="3">0.15</td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>No</td>
                <td>431 (94.4)</td>
                <td>30(73.1)</td>
                <td>0.14 (0.06 - 5.00)</td>
                <td>
                </td>
                <td>1</td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>8 (5.6)</td>
                <td>11(26.9)</td>
                <td>1.55 (0.35 - 11.13)</td>
                <td>0.22</td>
                <td>2.03 (0.49 - 18.28)</td>
                <td>0.77</td>
              </tr>
              <tr>
                <td>
                  <bold>Parity</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td rowspan="4">0.53</td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Primipara</td>
                <td>206(46.9)</td>
                <td>10(24.3)</td>
                <td>1</td>
                <td>
                </td>
                <td>1</td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Paucipara</td>
                <td>101(23.1)</td>
                <td>3 (7.3)</td>
                <td>0.19 (0.33 - 3.50)</td>
                <td>
                </td>
                <td>0.05 (0.02 - 1.55)</td>
                <td>0.21</td>
              </tr>
              <tr>
                <td>Multipara</td>
                <td>132(30.0)</td>
                <td>28(68.3)</td>
                <td>3.09 (0.33 - 33.60)</td>
                <td>
                  <bold>0.01</bold>
                </td>
                <td>2.05 (0.22 - 6.55)</td>
                <td>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Multiple sexual partners</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td rowspan="3">
                  <bold>0.008</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>No</td>
                <td>407 (92.7)</td>
                <td>15(84.8)</td>
                <td>1</td>
                <td>
                </td>
                <td>1</td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>32 (7.3)</td>
                <td>26 (15.2)</td>
                <td>2.42 (1.05 - 12.41)</td>
                <td>
                  <bold>0.04</bold>
                </td>
                <td>1.04 (0.05 - 5.55)</td>
                <td>0.47</td>
              </tr>
              <tr>
                <td>
                  <bold>Scarifications and share of sharp objects</bold>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td rowspan="3">
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>No</td>
                <td>321(73.1)</td>
                <td>30(73.1)</td>
                <td>1</td>
                <td>
                </td>
                <td>1</td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Yes</td>
                <td>118(26.9)</td>
                <td>11(26.9)</td>
                <td>1</td>
                <td>
                </td>
                <td>1</td>
                <td>
                </td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="sec3dot4">
        <title>3.4. Associated Factors to Viral Hepatitis B and C Infection in Pregnancy</title>
        <p>We found that being single (p = 0.0001), aged between 21 - 30 years (p = 0.005), having a family past history of viral hepatitis (p = 0.003), being a multipara (p = 0.01), and having multiple sexual partners(p = 0.04), were found to be significantly associated with viral hepatitis in pregnancy (P &lt; 0.05). A past history of blood transfusion, scarifications and sharing sharp objects or unsafed injections did not significantly increase the risk of viral hepatitis B and C infection in our studied population. See<bold>Table 4</bold>.</p>
        <p>In a multivariate analysis, family history of hepatitis B virus (AOR = 6.08; CI [0.22 - 11.67], p = 0.001), single marital status (AOR = 2.00; CI [0.68 - 21.02], p = 0.032) and age (21 - 30 years) (AOR = 4.40; CI [0.86 - 7.21], p = 0.005) were the factors independently associated with viral hepatitis in pregnancy among our studied population.</p>
      </sec>
    </sec>
    <sec id="sec4">
      <title>4. Discussion</title>
      <p>Viral hepatitis remains the main cause of hepatitis in pregnancy. Early detection enables effective prevention of mother-to-child infection. WHO in 2016 defines 3 levels of endemicity low endemicity (less than 2% seropositive), intermediate endemicity (2% to 7% seropositive), and high endemicity (&gt;8% seropositive) [<xref ref-type="bibr" rid="B1">1</xref>]. The same report classifies HCV prevalence as high (&gt;3.5%), Intermediate (1.5% 3.5%), and low (1.5%) [<xref ref-type="bibr" rid="B1">1</xref>]. Several studies done in Cameroon revealed that Cameroon is a highly endemic zone for hepatitis B and C infections [<xref ref-type="bibr" rid="B7">7</xref>][<xref ref-type="bibr" rid="B13">13</xref>]. </p>
      <sec id="sec4dot1">
        <title>4.1. Prevalence of Viral Hepatitis B and C Infections in Pregnancy</title>
        <p>In our study, the prevalence of HBsAg among pregnant women at the ERHC was 7.9%, reflecting Cameroon’s high endemicity. This prevalence is consistent with the results of various studies conducted in several countries [<xref ref-type="bibr" rid="B15">15</xref>][<xref ref-type="bibr" rid="B18">18</xref>][<xref ref-type="bibr" rid="B20">20</xref>]. However, our results differ from those obtained by Nlinwe <italic>et al</italic>. in Bamenda, Northwest Region, Cameroon, who found a lower prevalence (4.98%) of hepatitis B virus infection among pregnant women attending Bamenda Regional Hospital [<xref ref-type="bibr" rid="B13">13</xref>]. Similarly, Goel <italic>et al</italic>. found an even lower prevalence of hepatitis B (0.72%) among pregnant women receiving care at a tertiary healthcare facility [<xref ref-type="bibr" rid="B17">17</xref>]. Conversely, the prevalence of viral hepatitis B among pregnant women in our study is lower than that reported by Hassan <italic>et al</italic>. in Somalia (11.24%) [<xref ref-type="bibr" rid="B14">14</xref>]. </p>
        <p>The reasons for the variations in the prevalence of HBV in different studies might be due to sociodemographic differences, differences in behavioural practices and cultural practices towards the risk of HBV and HCV infection. Examining our patients’ clinical profiles, we found that the infrequent use of condoms and early age at first intercourse were common, possibly explaining this high prevalence. </p>
        <p>The high prevalence of HBsAg in our study indicates the need to prioritise the southern region of Cameroon in the prevention of viral hepatitis, by raising awareness of the risk factors for hepatitis B and C among the general population. During antenatal visits, talks on these risk factors should be increased, and all pregnant women should be systematically screened for HBsAg and hepatitis C antibodies during their first visit.</p>
        <p>The hepatitis B vaccination rate was low among our respondents, in line with several African studies [<xref ref-type="bibr" rid="B11">11</xref>]-[<xref ref-type="bibr" rid="B15">15</xref>]. Health professionals attending to pregnant women should raise awareness of the hepatitis B vaccine and offer it to those who are not infected. Policymakers could help reduce these problems by ensuring free screening and vaccination against the hepatitis B virus for pregnant women.</p>
        <p>The prevalence of HCV in pregnancy was 0.6%, which is lower than the results obtained by Foelifack <italic>et al</italic> in Yaounde in 2018 [<xref ref-type="bibr" rid="B24">24</xref>] which was 1.7%. This difference could be due to the fact that our population seemed younger than theirs and it is well known that the baseline risk may be lower in a population like ours, because age is strongly associated with cumulative exposure over time. When considering our studied population clinical characteristics we noticed a low blood transfusions rate, low practice of common risk behaviours (scarification, sharing razors, unsafe dental work, tattooing/piercing, etc.) Hence the opportunities for HCV to spread are fewer. Nevertheless, the available data point toward a low-to-moderate HCV seroprevalence among pregnant women in Cameroon—likely in the range of ~1–2% in some urban antenatal settings, though meta-analysis suggests that in broader or mixed settings it could be around 3%</p>
      </sec>
      <sec id="sec4dot2">
        <title>4.2. Associated Factors to Viral Hepatitis B and C Virus</title>
        <p>In a bivariate analysis, the following factors were significantly associated with viral hepatitis B and C infection: age group (21 - 30 years), marital status (single), family history of hepatitis B virus, multiparity, and multiple sexual partners. This is in line with the findings of several authors (6, 7, 15, 18).</p>
        <p>On the contrary, risk factors identified by several other authors (15 - 20), such as dental extraction, blood transfusions, and scarifications, were not significantly associated with viral hepatitis B and C infection in our study.</p>
        <p>The age group most affected by infection during pregnancy was 21 - 30 years. This age group is characterised by high promiscuity, which exposes them to various genital infections. However, Nlinwe <italic>et al</italic>. found a fairly high prevalence of HBV infection in the 27 - 38 age group among pregnant women in Bamenda [<xref ref-type="bibr" rid="B13">13</xref>]. Counselling on safe sexual behaviour in colleges and universities, where women of this age group can be found, seems necessary. This seems all the more important considering that the majority of our study population were women of this age group, most of whom declared infrequent condom use and no hepatitis B vaccination.</p>
        <p>In our study, single women were found to be at a higher risk of developing HBV and HCV infections. This finding is supported by a study conducted by Mve <italic>et al</italic>. [<xref ref-type="bibr" rid="B7">7</xref>], who also noted that unmarried individuals engage in riskier sexual behaviour, making them more prone to STIs such as HBV [<xref ref-type="bibr" rid="B16">16</xref>].</p>
        <p>Among the pregnant women in our study, those with a history of household contact with an HBV- or HCV-positive family member were significantly more likely to have these infections. These findings corroborate those of several other authors worldwide [<xref ref-type="bibr" rid="B7">7</xref>][<xref ref-type="bibr" rid="B15">15</xref>][<xref ref-type="bibr" rid="B18">18</xref>]. However, our results differ from those of Hassan <italic>et al</italic>. and Goel <italic>et al</italic>., who found no statistical significance between household contact and HBV infection [<xref ref-type="bibr" rid="B14">14</xref>][<xref ref-type="bibr" rid="B17">17</xref>]. These differences may be due to variations in hygiene practices, vaccination rates, and the availability of HBV and HCV screening methods. In our African setting, closer interpersonal interactions and the sharing of cutlery and sharp objects are commonplace, thereby increasing the transmission of HBV. Health personnel should educate HBV-infected pregnant women about the importance of encouraging their family members to undergo routine screening and vaccination against HBV, as this could reduce the transmission of HBV within the household. </p>
        <p>Having multiple sexual partners was significantly associated with HBV infection, in line with the findings of Robel <italic>et al</italic>. [<xref ref-type="bibr" rid="B18">18</xref>]. It is evident that unsafe sexual practices contribute to the spread of HBV. This could be explained by the fact that HBV can be present in blood, semen, and other bodily fluids exchanged during sexual contact. Differences in HBV and HCV prevalence in different studies may be due to variations in sexual health education, the availability of protective measures and access to STI management services. Our findings highlight the need to prevent the transmission of HBV infection, primarily by encouraging behavioural changes to promote safer sexual practices. Having multiple sexual partners is a factor frequently cited in the transmission of hepatitis B [<xref ref-type="bibr" rid="B22">22</xref>][<xref ref-type="bibr" rid="B23">23</xref>], and a cumulative number of sexual partners greater than two was the critical threshold associated with hepatitis B in pregnancy [<xref ref-type="bibr" rid="B23">23</xref>]. However, other studies found no association [<xref ref-type="bibr" rid="B15">15</xref>][<xref ref-type="bibr" rid="B16">16</xref>][<xref ref-type="bibr" rid="B20">20</xref>].</p>
        <p>In line with the results obtained by Goel <italic>et al</italic>., our study found that multiparous pregnant women were at a higher risk of screening positive for HBV and HCV infections, which could be explained by them undergoing more medical interventions, such as caesarean sections, blood transfusions, and other invasive procedures, which could increase the risk of HBV and HCV infections. Also, due to several deliveries, multiparous women may have been exposed to unsafe procedures during delivery.</p>
        <p>In a multivariate analysis after adjusting for other confounding factors, multiparity and having multiple sexual partners were no longer significantly associated to viral hepatitis B and C infection in pregnancy, while being a single pregnant woman, aged 21 - 30 and having a family past history of hepatitis B remained statistically significant.</p>
      </sec>
      <sec id="sec4dot3">
        <title>4.3. Strengths and Limitations</title>
        <p><bold>Strengths of the study</bold>: We used ELISA diagnostic method which has high sensitivity and specificity to confirm HBV and HCV infections. The study also used a standardized questionnaire to collect information from the study participants. </p>
        <p><bold>Limitations of the study:</bold> The study was conducted at a point in time hence rendering causal association impossible. The study was a hospital based study which may not be generalizable to the entire population.</p>
      </sec>
    </sec>
    <sec id="sec5">
      <title>5. Conclusions</title>
      <p>The seroprevalence of HBV infection among pregnant women in Ebolowa, Cameroon, is notably high, posing a significant public health concern, while HCV prevalence is low. Awareness of HBV vaccination should be increased and made available at no cost. Systematic screening during initial antenatal care visits is recommended, alongside preventative measures targetting this population. Targetted awareness campaigns should be organised for single women, aged (21 - 30) and family based screening programs put in place.</p>
      <p>Promoting education on HBV transmission and prevention at clinics, employing aseptic techniques in healthcare, and avoiding sharing sharp materials are essential at homes. Further community studies are necessary to evaluate overall HBV prevalence and risk associations.</p>
    </sec>
    <sec id="sec6">
      <title>Authors’ Contribution</title>
      <p><bold>Data design and acquisition:</bold> Messakop M.Y, Lendem I, Bisay S.U.B, </p>
      <p><bold>Data analysis and interpretation:</bold> Messakop M.Y, Aboui F, Mboua N.V, Bisay S.U.B, Bilo’o L, Atangana E.H, Elah C<bold>,</bold>Ndoumba A, Aboui F</p>
      <p><bold>Editing of the article:</bold>Messakop M.Y<bold>,</bold>Makemgue LS, Lendem I</p>
      <p><bold>Critical review of intellectual content</bold>: Makemgue LS, Bengono R, Foumane P, Ekono G.M</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">WHO (2016) Global Health Sector Strategy on Viral Hepatitis 2016-2021 towards Ending Viral Hepatitis. No. WHO/HIV/2016.06. World Health Organization.</mixed-citation>
          <element-citation publication-type="other">
            <year>2016</year>
            <article-title>Global Health Sector Strategy on Viral Hepatitis 2016-2021 towards Ending Viral Hepatitis</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">WHO (2015) Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. World Health Organization.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Prevention, C</string-name>
            </person-group>
            <year>2015</year>
            <article-title>Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">WHO (2022) Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection. World Health Organization.</mixed-citation>
          <element-citation publication-type="other">
            <year>2022</year>
            <article-title>Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Chilaka, V.N. and Konje, J.C. (2021) Viral Hepatitis in Pregnancy. <italic>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</italic>, 256, 287-296. https://doi.org/10.1016/j.ejogrb.2020.11.052 <pub-id pub-id-type="doi">10.1016/j.ejogrb.2020.11.052</pub-id><pub-id pub-id-type="pmid">33259998</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejogrb.2020.11.052">https://doi.org/10.1016/j.ejogrb.2020.11.052</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Chilaka, V.N.</string-name>
              <string-name>Konje, J.C.</string-name>
            </person-group>
            <year>2021</year>
            <article-title>Viral Hepatitis in Pregnancy</article-title>
            <source>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</source>
            <volume>256</volume>
            <pub-id pub-id-type="doi">10.1016/j.ejogrb.2020.11.052</pub-id>
            <pub-id pub-id-type="pmid">33259998</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Shata, M.T.M., Hetta, H.F., Sharma, Y. and Sherman, K.E. (2022) Viral Hepatitis in Pregnancy. <italic>Journal of Viral Hepatitis</italic>, 29, 844-861. https://doi.org/10.1111/jvh.13725 <pub-id pub-id-type="doi">10.1111/jvh.13725</pub-id><pub-id pub-id-type="pmid">35748741</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jvh.13725">https://doi.org/10.1111/jvh.13725</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Shata, M.T.M.</string-name>
              <string-name>Hetta, H.F.</string-name>
              <string-name>Sharma, Y.</string-name>
              <string-name>Sherman, K.E.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>Viral Hepatitis in Pregnancy</article-title>
            <source>Journal of Viral Hepatitis</source>
            <volume>29</volume>
            <pub-id pub-id-type="doi">10.1111/jvh.13725</pub-id>
            <pub-id pub-id-type="pmid">35748741</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">KpaiKpai, P., Yanogo, P.K., Halatoko, W. and Meda, N. (2022) Facteurs associés à l’hépatite b chez les femmes ayant accouché au district de sotouboua entre avril 2019 et mars 2020: Une étude transversale. <italic>Health Sciences and Disease</italic>, 23, 40-45.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>KpaiKpai, P.</string-name>
              <string-name>Yanogo, P.K.</string-name>
              <string-name>Halatoko, W.</string-name>
              <string-name>Meda, N.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>Facteurs associés à l’hépatite b chez les femmes ayant accouché au district de sotouboua entre avril 2019 et mars 2020: Une étude transversale</article-title>
            <source>Health Sciences and Disease</source>
            <volume>23</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Mve, K.V., Wambo, N.C., Essiben, F. and Mboudou, E.T. (2019) Facteurs associés au portage de l’aghbs en grossesse dans un pays de haute endémicité: Une étude cas-témoin. <italic>Health Sciences and Disease</italic>, 20, 1-7.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Mve, K.V.</string-name>
              <string-name>Wambo, N.C.</string-name>
              <string-name>Essiben, F.</string-name>
              <string-name>Mboudou, E.T.</string-name>
            </person-group>
            <year>2019</year>
            <article-title>Facteurs associés au portage de l’aghbs en grossesse dans un pays de haute endémicité: Une étude cas-témoin</article-title>
            <source>Health Sciences and Disease</source>
            <volume>20</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Bigna, J.J., Amougou, M.A., Asangbeh, S.L., Kenne, A.M., Noumegni, S.R.N., Ngo-Malabo, E.T., <italic>et al</italic><italic>.</italic> (2017) Seroprevalence of Hepatitis B Virus Infection in Cameroon: A Systematic Review and Meta-Analysis. <italic>BMJ Open</italic>, 7, e015298. https://doi.org/10.1136/bmjopen-2016-015298 <pub-id pub-id-type="doi">10.1136/bmjopen-2016-015298</pub-id><pub-id pub-id-type="pmid">28667212</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmjopen-2016-015298">https://doi.org/10.1136/bmjopen-2016-015298</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Bigna, J.J.</string-name>
              <string-name>Amougou, M.A.</string-name>
              <string-name>Asangbeh, S.L.</string-name>
              <string-name>Kenne, A.M.</string-name>
              <string-name>Noumegni, S.R.N.</string-name>
              <string-name>Ngo-Malabo, E.T.</string-name>
            </person-group>
            <year>2017</year>
            <article-title>Seroprevalence of Hepatitis B Virus Infection in Cameroon: A Systematic Review and Meta-Analysis</article-title>
            <source>BMJ Open</source>
            <volume>7</volume>
            <pub-id pub-id-type="doi">10.1136/bmjopen-2016-015298</pub-id>
            <pub-id pub-id-type="pmid">28667212</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Schweitzer, A., Horn, J., Mikolajczyk, R.T., Krause, G. and Ott, J.J. (2015) Estimations of Worldwide Prevalence of Chronic Hepatitis B Virus Infection: A Systematic Review of Data Published between 1965 and 2013. <italic>The Lancet</italic>, 386, 1546-1555. https://doi.org/10.1016/s0140-6736(15)61412-x <pub-id pub-id-type="doi">10.1016/s0140-6736(15)61412-x</pub-id><pub-id pub-id-type="pmid">26231459</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s0140-6736(15)61412-x">https://doi.org/10.1016/s0140-6736(15)61412-x</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Schweitzer, A.</string-name>
              <string-name>Horn, J.</string-name>
              <string-name>Mikolajczyk, R.T.</string-name>
              <string-name>Krause, G.</string-name>
              <string-name>Ott, J.J.</string-name>
            </person-group>
            <year>2015</year>
            <article-title>Estimations of Worldwide Prevalence of Chronic Hepatitis B Virus Infection: A Systematic Review of Data Published between 1965 and 2013</article-title>
            <source>The Lancet</source>
            <volume>6736</volume>
            <issue>15</issue>
            <pub-id pub-id-type="doi">10.1016/s0140-6736(15)61412-x</pub-id>
            <pub-id pub-id-type="pmid">26231459</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Spearman, C.W., Afihene, M., Ally, R., Apica, B., Awuku, Y., Cunha, L., <italic>et al</italic><italic>.</italic> (2017) Hepatitis B in Sub-Saharan Africa: Strategies to Achieve the 2030 Elimination Targets. <italic>The Lancet Gastroenterology &amp; Hepatology</italic>, 2, 900-909. https://doi.org/10.1016/s2468-1253(17)30295-9 <pub-id pub-id-type="doi">10.1016/s2468-1253(17)30295-9</pub-id><pub-id pub-id-type="pmid">29132759</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s2468-1253(17)30295-9">https://doi.org/10.1016/s2468-1253(17)30295-9</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Spearman, C.W.</string-name>
              <string-name>Afihene, M.</string-name>
              <string-name>Ally, R.</string-name>
              <string-name>Apica, B.</string-name>
              <string-name>Awuku, Y.</string-name>
              <string-name>Cunha, L.</string-name>
            </person-group>
            <year>2017</year>
            <article-title>Hepatitis B in Sub-Saharan Africa: Strategies to Achieve the 2030 Elimination Targets</article-title>
            <source>The Lancet Gastroenterology &amp; Hepatology</source>
            <volume>1253</volume>
            <issue>17</issue>
            <pub-id pub-id-type="doi">10.1016/s2468-1253(17)30295-9</pub-id>
            <pub-id pub-id-type="pmid">29132759</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Abongwa, L.E. and Pen, K. (2016) Assessing Prevalence and Risks Factors of Hepatitis B Surface Antigen Amongst Pregnant Women. <italic>European Journal of Research in Medical Sciences</italic>, 4, 32-43.</mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Abongwa, L.E.</string-name>
              <string-name>Pen, K.</string-name>
            </person-group>
            <year>2016</year>
            <article-title>Assessing Prevalence and Risks Factors of Hepatitis B Surface Antigen Amongst Pregnant Women</article-title>
            <source>European Journal of Research in Medical Sciences</source>
            <volume>4</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Alassan, K.S., Imorou, R.S., Sonombiti, H., Salifou, K. and Ouendo, E. (2019) Séroprévalence et facteurs associés à l’hépatite virale B chez les gestantes à Parakou en République du Bénin. <italic>Pan African Medical Journal</italic>, 33, Article 226. https://doi.org/10.11604/pamj.2019.33.226.19429 <pub-id pub-id-type="doi">10.11604/pamj.2019.33.226.19429</pub-id><pub-id pub-id-type="pmid">31692755</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.11604/pamj.2019.33.226.19429">https://doi.org/10.11604/pamj.2019.33.226.19429</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Alassan, K.S.</string-name>
              <string-name>Imorou, R.S.</string-name>
              <string-name>Sonombiti, H.</string-name>
              <string-name>Salifou, K.</string-name>
              <string-name>Ouendo, E.</string-name>
            </person-group>
            <year>2019</year>
            <article-title>Séroprévalence et facteurs associés à l’hépatite virale B chez les gestantes à Parakou en République du Bénin</article-title>
            <source>Pan African Medical Journal</source>
            <volume>33</volume>
            <elocation-id>226</elocation-id>
            <pub-id pub-id-type="doi">10.11604/pamj.2019.33.226.19429</pub-id>
            <pub-id pub-id-type="pmid">31692755</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Nlinwe, N.O. and Lungle, D. (2021) Risk Factors Associated with Hepatitis B Virus Infection among Pregnant Women Attending the Antenatal Care Unit of the Bamenda Regional Hospital. <italic>Public Health in Practice</italic>, 2, Article 100160. https://doi.org/10.1016/j.puhip.2021.100160 <pub-id pub-id-type="doi">10.1016/j.puhip.2021.100160</pub-id><pub-id pub-id-type="pmid">36101628</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.puhip.2021.100160">https://doi.org/10.1016/j.puhip.2021.100160</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Nlinwe, N.O.</string-name>
              <string-name>Lungle, D.</string-name>
            </person-group>
            <year>2021</year>
            <article-title>Risk Factors Associated with Hepatitis B Virus Infection among Pregnant Women Attending the Antenatal Care Unit of the Bamenda Regional Hospital</article-title>
            <source>Public Health in Practice</source>
            <volume>2</volume>
            <elocation-id>100160</elocation-id>
            <pub-id pub-id-type="doi">10.1016/j.puhip.2021.100160</pub-id>
            <pub-id pub-id-type="pmid">36101628</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Hassan, S.A., Ahmed, Y.M.A., Almugadam, B.S. and Hassan, Y.S.A. (2024) Prevalence and Associated Factors for Hepatitis B Infection among Pregnant Women Attending Antenatal Clinic at SOS Hospital in Mogadishu, Somalia. <italic>Frontiers in Global Women</italic>’ <italic>s Health</italic>, 5, Article ID: 1279088. https://doi.org/10.3389/fgwh.2024.1279088 <pub-id pub-id-type="doi">10.3389/fgwh.2024.1279088</pub-id><pub-id pub-id-type="pmid">38835408</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgwh.2024.1279088">https://doi.org/10.3389/fgwh.2024.1279088</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Hassan, S.A.</string-name>
              <string-name>Ahmed, Y.M.A.</string-name>
              <string-name>Almugadam, B.S.</string-name>
              <string-name>Hassan, Y.S.A.</string-name>
              <string-name>Mogadishu, S</string-name>
            </person-group>
            <year>2024</year>
            <article-title>Prevalence and Associated Factors for Hepatitis B Infection among Pregnant Women Attending Antenatal Clinic at SOS Hospital in Mogadishu, Somalia</article-title>
            <source>Frontiers in Global Women’s Health</source>
            <volume>5</volume>
            <fpage>127908</fpage>
            <elocation-id>ID</elocation-id>
            <pub-id pub-id-type="doi">10.3389/fgwh.2024.1279088</pub-id>
            <pub-id pub-id-type="pmid">38835408</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Mohammed, N., Kassim, J., Aliyi, A.A. and Abdurebi, M.J. (2025) Prevalence of Viral Hepatitis B and C Infection and Associated Factors among Pregnant Women in Southeast Ethiopia: Community-Based Crossectional Study. <italic>Frontiers in Global Women</italic>’ <italic>s Health</italic>, 6, Article ID: 1508788. https://doi.org/10.3389/fgwh.2025.1508788 <pub-id pub-id-type="doi">10.3389/fgwh.2025.1508788</pub-id><pub-id pub-id-type="pmid">39968399</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgwh.2025.1508788">https://doi.org/10.3389/fgwh.2025.1508788</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Mohammed, N.</string-name>
              <string-name>Kassim, J.</string-name>
              <string-name>Aliyi, A.A.</string-name>
              <string-name>Abdurebi, M.J.</string-name>
            </person-group>
            <year>2025</year>
            <article-title>Prevalence of Viral Hepatitis B and C Infection and Associated Factors among Pregnant Women in Southeast Ethiopia: Community-Based Crossectional Study</article-title>
            <source>Frontiers in Global Women’s Health</source>
            <volume>6</volume>
            <fpage>150878</fpage>
            <elocation-id>ID</elocation-id>
            <pub-id pub-id-type="doi">10.3389/fgwh.2025.1508788</pub-id>
            <pub-id pub-id-type="pmid">39968399</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Bigna, J.J., Kenne, A.M., Hamroun, A., Ndangang, M.S., Foka, A.J., Tounouga, D.N., <italic>et al</italic><italic>.</italic> (2019) Gender Development and Hepatitis B and C Infections among Pregnant Women in Africa: A Systematic Review and Meta-Analysis. <italic>Infectious Diseases of Poverty</italic>, 8, Article No. 16. https://doi.org/10.1186/s40249-019-0526-8 <pub-id pub-id-type="doi">10.1186/s40249-019-0526-8</pub-id><pub-id pub-id-type="pmid">30827278</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s40249-019-0526-8">https://doi.org/10.1186/s40249-019-0526-8</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Bigna, J.J.</string-name>
              <string-name>Kenne, A.M.</string-name>
              <string-name>Hamroun, A.</string-name>
              <string-name>Ndangang, M.S.</string-name>
              <string-name>Foka, A.J.</string-name>
              <string-name>Tounouga, D.N.</string-name>
            </person-group>
            <year>2019</year>
            <article-title>Gender Development and Hepatitis B and C Infections among Pregnant Women in Africa: A Systematic Review and Meta-Analysis</article-title>
            <source>Infectious Diseases of Poverty</source>
            <volume>8</volume>
            <elocation-id>No</elocation-id>
            <pub-id pub-id-type="doi">10.1186/s40249-019-0526-8</pub-id>
            <pub-id pub-id-type="pmid">30827278</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Goel, N., Sharma, R. and Agarwal, R. (2020) Seroprevalence of Hepatitis B and Hepatitis C Viral Infections in Pregnant Women Attending Antenatal Clinic in Tertiary Care Centre. <italic>IP International Journal of Medical Microbiology and Tropical Diseases</italic>, 6, 86-89. https://doi.org/10.18231/j.ijmmtd.2020.018 <pub-id pub-id-type="doi">10.18231/j.ijmmtd.2020.018</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18231/j.ijmmtd.2020.018">https://doi.org/10.18231/j.ijmmtd.2020.018</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Goel, N.</string-name>
              <string-name>Sharma, R.</string-name>
              <string-name>Agarwal, R.</string-name>
            </person-group>
            <year>2020</year>
            <article-title>Seroprevalence of Hepatitis B and Hepatitis C Viral Infections in Pregnant Women Attending Antenatal Clinic in Tertiary Care Centre</article-title>
            <source>IP International Journal of Medical Microbiology and Tropical Diseases</source>
            <volume>6</volume>
            <pub-id pub-id-type="doi">10.18231/j.ijmmtd.2020.018</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Roble, A.K., Roba, K.T., Mengistie, B. and Abdurke Kure, M. (2021) Seroprevalence of Hepatitis B Virus and Associated Factors among Pregnant Women Attending Antenatal Care in Public Health Facilities in Jigjiga Town, Eastern Ethiopia. <italic>International Journal of Women</italic>’ <italic>s Health</italic>, 12, 1299-1310. https://doi.org/10.2147/ijwh.s276526 <pub-id pub-id-type="doi">10.2147/ijwh.s276526</pub-id><pub-id pub-id-type="pmid">33447090</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2147/ijwh.s276526">https://doi.org/10.2147/ijwh.s276526</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Roble, A.K.</string-name>
              <string-name>Roba, K.T.</string-name>
              <string-name>Mengistie, B.</string-name>
              <string-name>Kure, M.</string-name>
              <string-name>Town, E</string-name>
            </person-group>
            <year>2021</year>
            <article-title>Seroprevalence of Hepatitis B Virus and Associated Factors among Pregnant Women Attending Antenatal Care in Public Health Facilities in Jigjiga Town, Eastern Ethiopia</article-title>
            <source>International Journal of Women’s Health</source>
            <volume>12</volume>
            <pub-id pub-id-type="doi">10.2147/ijwh.s276526</pub-id>
            <pub-id pub-id-type="pmid">33447090</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Workye, H., Niguse, M., Tadesse, I. and Karim, A. (2022) Prevalence and Associated Factors of Hepatitis B Virus Infection among Pregnant Women Attending Antenatal Care in Agena Health Center, South Ethiopia: A Cross-Sectional Study. <italic>Journal of Clinical Cellular Immunology</italic>, 13, 1-6.</mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Workye, H.</string-name>
              <string-name>Niguse, M.</string-name>
              <string-name>Tadesse, I.</string-name>
              <string-name>Karim, A.</string-name>
              <string-name>Center, S</string-name>
            </person-group>
            <year>2022</year>
            <article-title>Prevalence and Associated Factors of Hepatitis B Virus Infection among Pregnant Women Attending Antenatal Care in Agena Health Center, South Ethiopia: A Cross-Sectional Study</article-title>
            <source>Journal of Clinical Cellular Immunology</source>
            <volume>13</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Tanga, A.T., Teshome, M.A., Hiko, D., Fikru, C. and Jilo, G.K. (2019) Sero-Prevalence of Hepatitis B Virus and Associated Factors among Pregnant Women in Gambella Hospital, South Western Ethiopia: Facility Based Cross-Sectional Study. <italic>BMC Infectious Diseases</italic>, 19, Article No. 602. https://doi.org/10.1186/s12879-019-4220-z <pub-id pub-id-type="doi">10.1186/s12879-019-4220-z</pub-id><pub-id pub-id-type="pmid">31291901</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12879-019-4220-z">https://doi.org/10.1186/s12879-019-4220-z</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Tanga, A.T.</string-name>
              <string-name>Teshome, M.A.</string-name>
              <string-name>Hiko, D.</string-name>
              <string-name>Fikru, C.</string-name>
              <string-name>Jilo, G.K.</string-name>
              <string-name>Hospital, S</string-name>
            </person-group>
            <year>2019</year>
            <article-title>Sero-Prevalence of Hepatitis B Virus and Associated Factors among Pregnant Women in Gambella Hospital, South Western Ethiopia: Facility Based Cross-Sectional Study</article-title>
            <source>BMC Infectious Diseases</source>
            <volume>19</volume>
            <elocation-id>No</elocation-id>
            <pub-id pub-id-type="doi">10.1186/s12879-019-4220-z</pub-id>
            <pub-id pub-id-type="pmid">31291901</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Araya Mezgebo, T., Niguse, S., Gebrekidan Kahsay, A., Hailekiros, H., Berhe, N. and Asmelash Dejene, T. (2018) Hepatitis B Virus Infection and Associated Risk Factors among Pregnant Women Attending Antenatal Care in Health Facilities of Tigray, Northern Ethiopia. <italic>Journal of Medical Virology</italic>, 90, 503-509. https://doi.org/10.1002/jmv.24987 <pub-id pub-id-type="doi">10.1002/jmv.24987</pub-id><pub-id pub-id-type="pmid">29077204</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jmv.24987">https://doi.org/10.1002/jmv.24987</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Mezgebo, T.</string-name>
              <string-name>Niguse, S.</string-name>
              <string-name>Kahsay, A.</string-name>
              <string-name>Hailekiros, H.</string-name>
              <string-name>Berhe, N.</string-name>
              <string-name>Dejene, T.</string-name>
              <string-name>Tigray, N</string-name>
            </person-group>
            <year>2018</year>
            <article-title>Hepatitis B Virus Infection and Associated Risk Factors among Pregnant Women Attending Antenatal Care in Health Facilities of Tigray, Northern Ethiopia</article-title>
            <source>Journal of Medical Virology</source>
            <volume>90</volume>
            <pub-id pub-id-type="doi">10.1002/jmv.24987</pub-id>
            <pub-id pub-id-type="pmid">29077204</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Bayo, P., Ochola, E., Oleo, C. and Mwaka, A.D. (2014) High Prevalence of Hepatitis B Virus Infection among Pregnant Women Attending Antenatal Care: A Cross-Sectional Study in Two Hospitals in Northern Uganda. <italic>BMJ Open</italic>, 4, e005889. https://doi.org/10.1136/bmjopen-2014-005889 <pub-id pub-id-type="doi">10.1136/bmjopen-2014-005889</pub-id><pub-id pub-id-type="pmid">25387757</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmjopen-2014-005889">https://doi.org/10.1136/bmjopen-2014-005889</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Bayo, P.</string-name>
              <string-name>Ochola, E.</string-name>
              <string-name>Oleo, C.</string-name>
              <string-name>Mwaka, A.D.</string-name>
            </person-group>
            <year>2014</year>
            <article-title>High Prevalence of Hepatitis B Virus Infection among Pregnant Women Attending Antenatal Care: A Cross-Sectional Study in Two Hospitals in Northern Uganda</article-title>
            <source>BMJ Open</source>
            <volume>4</volume>
            <pub-id pub-id-type="doi">10.1136/bmjopen-2014-005889</pub-id>
            <pub-id pub-id-type="pmid">25387757</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Luksamijarulkul, P., Mooktaragosa, A. and Luksamijarulkul, S. (2002) Risk Factors for Hepatitis B Surface Antigen Positivity among Pregnant Women. <italic>Journal of the Medical Association of Thailand</italic>, 85, 283-288.</mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Luksamijarulkul, P.</string-name>
              <string-name>Mooktaragosa, A.</string-name>
              <string-name>Luksamijarulkul, S.</string-name>
            </person-group>
            <year>2002</year>
            <article-title>Risk Factors for Hepatitis B Surface Antigen Positivity among Pregnant Women</article-title>
            <source>Journal of the Medical Association of Thailand</source>
            <volume>85</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Fouelifack, F.Y., Fouedjio, J.H., Fouogue, J.T. and Fouelifa, L.D. (2018) Seroprevalences and Correlates of Hepatitis B and C among Cameroonian Pregnant Women. <italic>Clinical Medicine Insights</italic>: <italic>Reproductive Health</italic>, 12, 1-6. https://doi.org/10.1177/1179558118770671 <pub-id pub-id-type="doi">10.1177/1179558118770671</pub-id><pub-id pub-id-type="pmid">29692639</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/1179558118770671">https://doi.org/10.1177/1179558118770671</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Fouelifack, F.Y.</string-name>
              <string-name>Fouedjio, J.H.</string-name>
              <string-name>Fouogue, J.T.</string-name>
              <string-name>Fouelifa, L.D.</string-name>
            </person-group>
            <year>2018</year>
            <article-title>Seroprevalences and Correlates of Hepatitis B and C among Cameroonian Pregnant Women</article-title>
            <source>Clinical Medicine Insights: Reproductive Health</source>
            <volume>12</volume>
            <pub-id pub-id-type="doi">10.1177/1179558118770671</pub-id>
            <pub-id pub-id-type="pmid">29692639</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
    </ref-list>
  </back>
</article>